Ifeoma Okoye
Overview
Explore the profile of Ifeoma Okoye including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
58
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bello S, Imam M, Bello M, Yunusa A, Adamu A, Shuaibu A, et al.
Front Cell Infect Microbiol
. 2023 Dec;
13:1273982.
PMID: 38089816
Background: Although tremendous success has been achieved in the development and deployment of effective COVID-19 vaccines, developing effective therapeutics for the treatment of those who do come down with the...
2.
Bello S, Yunusa A, Adamu A, Imam M, Bello M, Shuaibu A, et al.
Front Pharmacol
. 2023 Mar;
14:1130828.
PMID: 36937851
Several efforts to repurpose drugs for COVID-19 treatment have largely either failed to identify a suitable agent or agents identified did not translate to clinical use. Reasons that have been...
3.
Alao M, Raji Y, Asinobi O, Akinboro A, Ngene S, Olayinka I, et al.
Pan Afr Med J
. 2022 Aug;
42:77.
PMID: 36034035
Graft survival after kidney transplantation may be influenced by both donors' and recipients' Apoprotein 1 (APOL1) risk variant status. There are several conflicting reports on screening, eligibility, and inclusion of...
4.
Ibraheem A, Pillai C, Okoye I, Smith J, Reidy-Lagunes D, Macaulay G, et al.
JCO Glob Oncol
. 2021 Sep;
7:1358-1363.
PMID: 34506222
Cancer is now a formidable health care burden in sub-Saharan Africa (SSA) due to lifestyle westernization and longer life expectancy. The exponential increase in cancer incidence coupled with high mortality...
5.
Shamley D, Ezeani A, Okoye I
JCO Glob Oncol
. 2021 Apr;
7:572-576.
PMID: 33886365
Oncology clinical trials are requisite for testing the safety and effectiveness of promising treatments and deciphering new knowledge into concrete benefits for patients. They present opportunities to innovate promising, novel...
6.
Ajidahun A, Myezwa H, Ibeneme S, Magobotha S, Fortwengel G, Jingo M, et al.
Medicine (Baltimore)
. 2020 Dec;
99(50):e23206.
PMID: 33327237
Introduction: Human Immunodeficiency Virus (HIV) infection remains prevalent co-morbidity, and among fracture patients. Few studies have investigated the role of exercise interventions in preventing bone demineralization in people who have...
7.
Odedina F, Shamley D, Okoye I, Ezeani A, Ndlovu N, Dei-Adomakoh Y, et al.
JCO Glob Oncol
. 2020 Jul;
6:932-941.
PMID: 32614728
Purpose: The burden of cancer in Africa is of significant concern for several reasons, including that incidence of cancer in Africa continues to rise while Africa is also dealing with...
8.
Graef K, Okoye I, Ohene Oti N, Dent J, Odedina F
JCO Glob Oncol
. 2020 Jul;
6:973-982.
PMID: 32614727
Purpose: In a dramatic reversal of longstanding trends, cancer now kills more Africans than malaria. Despite Africa's growing cancer burden, individuals of African descent, notably those residing in Africa, remain...
9.
Ibeneme S, Ezeigwe C, Ibeneme G, Ezuma A, Okoye I, Nwankwo J
Curr Ther Res Clin Exp
. 2019 Aug;
90:92-98.
PMID: 31388361
Background: Available preliminary data on menopause does not relate changes in body fat mass (BFM) and handgrip strength (HGS) (an indicator of body/muscle strength) to gait parameters. Objective: To determine...
10.
Nwogu C, Mahoney M, Okoye I, Ejiogu K, George S, Dy G, et al.
J Cancer Epidemiol
. 2017 Jan;
2016:7121527.
PMID: 28070189
About 65% of cancer deaths globally occur in low to middle income countries (LMICs) where prioritization and allocation of resources to cancer care are often quite poor. In the absence...